✦ LIBER ✦

Pharmacokinetics and Pharmacodynamics of Liraglutide, a Long-Acting, Potent Glucagon-Like Peptide-1 Analog

✍ Scribed by Jerry Meece

Book ID: 115049953
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 109 KB
Volume: 29
Category: Article
ISSN: 0277-0008
DOI: 10.1592/phco.29.pt2.33s

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, tolerability, pharmacodynamics a

Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in healthy subjects

✍ M. A. Bush; J. E. Matthews; E. H. De Boever; R. L. Dobbins; R. J. Hodge; S. E. W 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

Liraglutide, a long-acting human glucago

Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture

✍ Christian Toso; Michael McCall; Juliet Emamaullee; Shaheed Merani; Joy Davis; Ry 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 278 KB

Pharmacodynamics, Pharmacokinetics, Safe

Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Albiglutide, a Long-Acting Glucagon-Like Peptide-1 Mimetic, in Patients with Type 2 Diabetes

✍ Matthews, Jessica E.; Stewart, Murray W.; De Boever, Erika H.; Dobbins, Robert L 📂 Article 📅 2008 🏛 Endocrine Society 🌐 English ⚖ 156 KB

The effect of the once-daily human gluca

The effect of the once-daily human glucagon-like peptide 1 analog liraglutide on the pharmacokinetics of acetaminophen

✍ Christoph Kapitza; Milan Zdravkovic; Charlotte Hindsberger; Anne Flint 📂 Article 📅 2011 🏛 Springer Healthcare Communications 🌐 English ⚖ 613 KB

Effects of the long-acting human glucago

Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on plasma omentin-1 levels in patients with type 2 diabetes mellitus

✍ Pijun Yan; Ling Li; Mengliu Yang; Dongfang Liu; Hua Liu; Guenther Boden; Gangyi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 220 KB

Pharmacokinetic and pharmacodynamic eval

Pharmacokinetic and pharmacodynamic evaluation of site-specific PEGylated glucagon-like peptide-1 analogs as flexible postprandial-glucose controllers

✍ Su Young Chae; Young Goo Chun; Seulki Lee; Cheng-Hao Jin; Eun Seong Lee; Kang Ch 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 337 KB

The rapid elimination of glucagon-like peptide-1 (GLP-1) is the main impediment to its anti-diabetic utility. Here, we tried to improve its poor pharmacokinetic/pharmacodynamic profiles using PEGylation. The site-specific (Lys 34 ) PEGylated GLP-1s were synthesized with PEGs of 2, 5, and 10 kDa, res